Biostar to market UTI test:
This article was originally published in Clinica
Executive Summary
Biostar will market Meridian Diagnostics' one-minute urinary tract infection test, FiltraCheck-UTI, to the US outpatient market. Privately-owned Biostar, based in Boulder, Colorado, will have exclusive rights to the test for the alternate site market, where over 60 million urinary screening tests are performed each year in the US. Meridian, which will manufacture the tests for Biostar, will continue to market it to hospitals and commercial laboratories. An application has been filed with the FDA for approval to sell FiltraCheck-UTI over-the-counter, for which Johnson & Johnson's Direct Access Diagnostics has marketing rights.